Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research Units
Equipment
Projects
Research output
Prizes
Activities
Press / Media
Search by expertise, name or affiliation
A phase II study of Avelumab + stereotactic ablative body radiosurgery (SABR) for metastatic castration-resistant prostate cancer (mCRPC)
Kwan, Edmond
(Primary Chief Investigator (PCI))
Medicine Monash Health
Project
:
Research
Overview
Project Details
Project Description
NMA HREC Reference Number: HREC/17/MonH/29
NMA SSA Reference Number: SSA/17/MonH/289
Monash Health Ref: 17-0000-082A
Status
Active
Effective start/end date
4/01/19
→
3/01/24
View all
View less